157 related articles for article (PubMed ID: 29314418)
1. Cerebral blood volume mapping with ferumoxytol in dynamic susceptibility contrast perfusion MRI: Comparison to standard of care.
Varallyay CG; Nesbit E; Horvath A; Varallyay P; Fu R; Gahramanov S; Muldoon LL; Li X; Rooney WD; Neuwelt EA
J Magn Reson Imaging; 2018 Aug; 48(2):441-448. PubMed ID: 29314418
[TBL] [Abstract][Full Text] [Related]
2. Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study.
Gahramanov S; Raslan AM; Muldoon LL; Hamilton BE; Rooney WD; Varallyay CG; Njus JM; Haluska M; Neuwelt EA
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):514-23. PubMed ID: 20395065
[TBL] [Abstract][Full Text] [Related]
3. High-resolution steady-state cerebral blood volume maps in patients with central nervous system neoplasms using ferumoxytol, a superparamagnetic iron oxide nanoparticle.
Varallyay CG; Nesbit E; Fu R; Gahramanov S; Moloney B; Earl E; Muldoon LL; Li X; Rooney WD; Neuwelt EA
J Cereb Blood Flow Metab; 2013 May; 33(5):780-6. PubMed ID: 23486297
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging of intracranial tumors: intra-patient comparison of gadoteridol and ferumoxytol.
Dósa E; Guillaume DJ; Haluska M; Lacy CA; Hamilton BE; Njus JM; Rooney WD; Kraemer DF; Muldoon LL; Neuwelt EA
Neuro Oncol; 2011 Feb; 13(2):251-60. PubMed ID: 21163809
[TBL] [Abstract][Full Text] [Related]
5. Pseudoprogression of glioblastoma after chemo- and radiation therapy: diagnosis by using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging with ferumoxytol versus gadoteridol and correlation with survival.
Gahramanov S; Muldoon LL; Varallyay CG; Li X; Kraemer DF; Fu R; Hamilton BE; Rooney WD; Neuwelt EA
Radiology; 2013 Mar; 266(3):842-52. PubMed ID: 23204544
[TBL] [Abstract][Full Text] [Related]
6. Quantitative comparison of delayed ferumoxytol T
Horváth A; Varallyay CG; Schwartz D; Toth GB; Netto JP; Barajas R; Várallyay P; Szidonya L; Firkins J; Youngers E; Fu R; Ambady P; Bogner P; Neuwelt EA
Magn Reson Med; 2018 Jul; 80(1):224-230. PubMed ID: 29205477
[TBL] [Abstract][Full Text] [Related]
7. Dual contrast perfusion MRI in a single imaging session for assessment of pediatric brain tumors.
Thompson EM; Guillaume DJ; Dósa E; Li X; Nazemi KJ; Gahramanov S; Hamilton BE; Neuwelt EA
J Neurooncol; 2012 Aug; 109(1):105-14. PubMed ID: 22528798
[TBL] [Abstract][Full Text] [Related]
8. Comparison of ferumoxytol-based cerebral blood volume estimates using quantitative R
Rivera-Rivera LA; Schubert T; Knobloch G; Turski PA; Wieben O; Reeder SB; Johnson KM
Magn Reson Med; 2018 Jun; 79(6):3072-3081. PubMed ID: 29096054
[TBL] [Abstract][Full Text] [Related]
9. Improved perfusion MR imaging assessment of intracerebral tumor blood volume and antiangiogenic therapy efficacy in a rat model with ferumoxytol.
Gahramanov S; Muldoon LL; Li X; Neuwelt EA
Radiology; 2011 Dec; 261(3):796-804. PubMed ID: 21940504
[TBL] [Abstract][Full Text] [Related]
10. Iron Sucrose as MRI Contrast Agent in Ischemic Stroke Model.
Wu S; Zhang H; Wang J; Li X; Gao X; Fang Z; Qu J; Wu Y; Ren Y; Rui W; Zhang J; Yao Z
J Magn Reson Imaging; 2020 Sep; 52(3):836-849. PubMed ID: 32112623
[TBL] [Abstract][Full Text] [Related]
11. Synthetic generation of DSC-MRI-derived relative CBV maps from DCE MRI of brain tumors.
Sanders JW; Chen HS; Johnson JM; Schomer DF; Jimenez JE; Ma J; Liu HL
Magn Reson Med; 2021 Jan; 85(1):469-479. PubMed ID: 32726488
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging.
Hamilton BE; Nesbit GM; Dosa E; Gahramanov S; Rooney B; Nesbit EG; Raines J; Neuwelt EA
AJR Am J Roentgenol; 2011 Oct; 197(4):981-8. PubMed ID: 21940589
[TBL] [Abstract][Full Text] [Related]
13. Measurements of cerebral blood volume using quantitative susceptibility mapping, R
Rivera-Rivera LA; Schubert T; Johnson KM
NMR Biomed; 2019 Dec; 32(12):e4175. PubMed ID: 31482602
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of an fMRI USPIO-based assay in healthy human volunteers.
Baumgartner R; Cho W; Coimbra A; Chen C; Wang Z; Struyk A; Venketasubramanian N; Low M; Gargano C; Zhao F; Williams D; Reese T; Seah S; Feng D; Apreleva S; Petersen E; Evelhoch JL
J Magn Reson Imaging; 2017 Jul; 46(1):124-133. PubMed ID: 27775841
[TBL] [Abstract][Full Text] [Related]
15. Dynamic susceptibility MR perfusion imaging of the brain: not a question of contrast agent molarity.
Panara V; Chiacchiaretta P; Rapino M; Maruotti V; Parenti M; Piccirilli E; Pizzi AD; Caulo M
Neuroradiology; 2022 Apr; 64(4):685-692. PubMed ID: 34557937
[TBL] [Abstract][Full Text] [Related]
16. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
Thomsen H; Steffensen E; Larsson EM
Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
[TBL] [Abstract][Full Text] [Related]
17. Ferumoxytol enhanced resting state fMRI and relative cerebral blood volume mapping in normal human brain.
D'Arceuil H; Coimbra A; Triano P; Dougherty M; Mello J; Moseley M; Glover G; Lansberg M; Blankenberg F
Neuroimage; 2013 Dec; 83():200-9. PubMed ID: 23831413
[TBL] [Abstract][Full Text] [Related]
18. Inter-individual Comparison of Gadobutrol and Gadoteridol Tissue Time-intensity Profiles for Dynamic Susceptibility Contrast Perfusion MR Imaging.
Yamada M; Taoka T; Kawaguchi A; Yasuda K; Niinomi Y; Ohashi Y; Okuda T; Naganawa S
Magn Reson Med Sci; 2019 Jan; 18(1):75-81. PubMed ID: 29794406
[TBL] [Abstract][Full Text] [Related]
19. Misleading early blood volume changes obtained using ferumoxytol-based magnetic resonance imaging perfusion in high grade glial neoplasms treated with bevacizumab.
Netto JP; Schwartz D; Varallyay C; Fu R; Hamilton B; Neuwelt EA
Fluids Barriers CNS; 2016 Dec; 13(1):23. PubMed ID: 27998280
[TBL] [Abstract][Full Text] [Related]
20. Comparison of contrast agents with high molarity and with weak protein binding in cerebral perfusion imaging at 3 T.
Thilmann O; Larsson EM; Björkman-Burtscher IM; Ståhlberg F; Wirestam R
J Magn Reson Imaging; 2005 Nov; 22(5):597-604. PubMed ID: 16200539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
